New York, NY – (NISMAGAZINE) – 04/07/2013- Zogenix, Inc. (NASDAQ:ZGNX) was down by 12.57% and closed to $1.57. The 52-week range of the stock is $1.51 and $1.79 and the stock is trading 40.99% above its 52-week low. The market capitalization of the stock is $157.77 million with about 100.81 million outstanding shares. The stock is trading below its 50 days moving average of $2.08; the chart of the stock is technically weak and the RSI of the stock is 35.54. The EPS of the stock is negative of $0.61. With an average volume of 1.79 million; 1.39 million shares exchanged hands in its last trading session. ZGNX is expected to receive a FDA’s decision regarding the approval of Zohydro ER and there are bleak chances that the company will get an approval.
How Should Investors Trade ZGNX Now? Find out here.
Cereplast Inc (PINK:CERP) closed to $0.0220 down by 5.17%. The market capitalization of the stock is $0.76 million with about 34.34 million outstanding shares. Around 3.42 million shares exchanged hands in last trading session, where the average volume of the stock is 11.33 million shares. The stock has a negative EPS of $1.08. The stock is facing a choppy session with a slight downward trend. The stock is trading below its 50 days moving average of $0.0323 and the RSI of the stock now standing at 41.83.
How Should Investors Trade CERP Now? Find out here.
Cell Therapeutics Inc (NASDAQ:CTIC) was down by 3.60% and closed to $1.07. The market capitalization of the stock is $103.78 million with about 96.99 million outstanding shares. The 52-week range of the stock is $1.02 and $6.75 and the stock is trading marginally 4.90% above its 52-week low. The stock has a beta of 5.29; the price to book value ratio of the stock is 3.34 whereas the price to cash flow of the stock is 8.22. The stock has declined since past three months and is now trading below its 50 days moving average of $1.31, the RSI of the stock is now standing at 34.31. The average volume of the stock is 1.33 million; 0.95 million shares exchanged hands in its last trading session. The ROA, ROE and ROI of the stock stands at -108.12%, -1,405.02% and -215.62% respectively.
Is CTIC a solid investment at these levels? Find out here.
Subscribe for FREE to receive our “50 Stock Trading Rules No Hedge Fund Wants You To Know!” E-Book: http://hiddengemstocks.com/trade.html
HiddenGemStocks.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
HiddenGemStocks.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit HiddenGemStocks.com website, for complete risks and disclosures.